Works by Lee, Mei-Hsuan


Results: 65
    1
    2
    3
    4
    5

    Cover Image, Volume 49, Issue 2.

    Published in:
    Neuropathology & Applied Neurobiology, 2023, v. 49, n. 1, p. 1, doi. 10.1111/nan.12901
    By:
    • Huang, Chia‐Wei;
    • Lee, Kuang‐Yung;
    • Lin, Peng‐Tzu;
    • Nian, Fang‐Shin;
    • Cheng, Haw‐Yuan;
    • Chang, Chien‐Hui;
    • Liao, Cheng‐Yen;
    • Su, Yen‐Lin;
    • Seah, Carol;
    • Li, Ching;
    • Chen, Yu‐Fu;
    • Lee, Mei‐Hsuan;
    • Tsai, Jin‐Wu
    Publication type:
    Article
    6
    7
    8

    Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 5, p. 558, doi. 10.1111/apt.16752
    By:
    • Hu, Hui‐Han;
    • Jeng, Wen‐Juei;
    • Pan, Mei‐Hung;
    • Luo, Wun‐Sheng;
    • Chang, Chia‐Ling;
    • Huang, Yen‐Tsung;
    • Su, Chien‐Yu;
    • Chiang, Chen‐Tse;
    • Jen, Chin‐Lan;
    • Chien, Yu‐Chuan;
    • Lu, Shen‐Nan;
    • Wang, Li‐Yu;
    • Huang, Li‐Rung;
    • Lee, Mei‐Hsuan;
    • Liu, Jessica;
    • Nguyen, Mindie H.;
    • Chen, Chien‐Jen;
    • Yang, Hwai‐I
    Publication type:
    Article
    9
    10
    11

    Large‐scale genome‐wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 4, p. 682, doi. 10.1111/apt.15887
    By:
    • Huang, Yu‐Han;
    • Liao, Shu‐Fen;
    • Khor, Seik‐Soon;
    • Lin, Yu‐Ju;
    • Chen, Hsuan‐Yu;
    • Chang, Ya‐Hsuan;
    • Huang, Yi‐Hsiang;
    • Lu, Sheng‐Nan;
    • Lee, Hye‐Won;
    • Ko, Wen‐Ya;
    • Huang, Claire;
    • Liu, Po‐Chun;
    • Chen, Yen‐Ju;
    • Wu, Ping‐Feng;
    • Chu, Hou‐Wei;
    • Wu, Pei‐Ei;
    • Tokunaga, Katsushi;
    • Shen, Chen‐Yang;
    • Lee, Mei‐Hsuan
    Publication type:
    Article
    12
    13
    14
    15
    16

    A Glycomarker for Short-term Prediction of Hepatocellular Carcinoma: A Longitudinal Study With Serial Measurements.

    Published in:
    Clinical & Translational Gastroenterology, 2018, v. 9, n. 9, p. 1, doi. 10.1038/s41424-018-0050-3
    By:
    • Lin, Yu-Ju;
    • Chang, Chia-Ling;
    • Chen, Liang-Chun;
    • Hu, Hui-Han;
    • Liu, Jessica;
    • Korenaga, Massaki;
    • Huang, Yu-Han;
    • Jen, Chin-Lan;
    • Su, Chien-Yu;
    • Nishida, Nao;
    • Sugiyama, Masaya;
    • Lu, Sheng-Nan;
    • Wang, Li-Yu;
    • Yuan, Yong;
    • L’Italien, Gilbert;
    • Yang, Hwai-I;
    • Mizokami, Masashi;
    • Chen, Chien-Jen;
    • Lee, Mei-Hsuan
    Publication type:
    Article
    17
    18
    19
    20
    21
    22

    Prevalence, proportions of elevated liver enzyme levels, and long‐term cardiometabolic mortality of patients with metabolic dysfunction‐associated steatotic liver disease.

    Published in:
    Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 9, p. 1939, doi. 10.1111/jgh.16592
    By:
    • Chen, Yi‐Ting;
    • Chen, Tzu‐I;
    • Yin, Szu‐Ching;
    • Huang, Chia‐Wei;
    • Huang, Jee‐Fu;
    • Lu, Sheng‐Nan;
    • Yeh, Ming‐Lun;
    • Huang, Chung‐Feng;
    • Dai, Chia‐Yen;
    • Chen, Yu‐Wei;
    • Chuang, Wan‐Long;
    • Yu, Ming‐Lung;
    • Lee, Mei‐Hsuan
    Publication type:
    Article
    23
    24

    Real-world treatment patterns and clinical outcomes of HCV treatment-naive patients in China: an interim analysis from the CCgenos study.

    Published in:
    Journal of Gastroenterology & Hepatology, 2017, v. 32, n. 1, p. 244, doi. 10.1111/jgh.13467
    By:
    • Rao, Hui ‐ ying;
    • Li, Hong;
    • Chen, Hong;
    • Shang, Jia;
    • Xie, Qing;
    • Gao, Zhi ‐ Liang;
    • Li, Jun;
    • Sun, Yongtao;
    • Jiang, Jianning;
    • Wang, Lei;
    • Zhao, Longfeng;
    • Zhang, Lunli;
    • Yang, Weibo;
    • Niu, Junqi;
    • Gong, Zuojiong;
    • Gong, Guozhong;
    • Yang, Ruifeng;
    • Lee, Mei ‐ Hsuan;
    • Wei, Lai
    Publication type:
    Article
    25
    26
    27
    28
    29
    30

    Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung Adenocarcinoma.

    Published in:
    Cancers, 2020, v. 12, n. 3, p. 755, doi. 10.3390/cancers12030755
    By:
    • Raghav, Lovely;
    • Chang, Ya-Hsuan;
    • Hsu, Yi-Chiung;
    • Li, Yu-Cheng;
    • Chen, Chih-Yi;
    • Yang, Tsung-Ying;
    • Chen, Kun-Chieh;
    • Hsu, Kuo-Hsuan;
    • Tseng, Jeng-Sen;
    • Chuang, Cheng-Yen;
    • Lee, Mei-Hsuan;
    • Wang, Chih-Liang;
    • Chen, Huei-Wen;
    • Yu, Sung-Liang;
    • Su, Sheng-Fang;
    • Yuan, Shin-Sheng;
    • Chen, Jeremy J.W.;
    • Ho, Shinn-Ying;
    • Li, Ker-Chau;
    • Yang, Pan-Chyr
    Publication type:
    Article
    31
    32
    33

    Clinical outcome of bevacizumab or ramucirumab combined with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors as the first line therapy in susceptible EGFR‐mutated advanced non‐small‐cell lung.

    Published in:
    Kaohsiung Journal of Medical Sciences, 2024, v. 40, n. 5, p. 467, doi. 10.1002/kjm2.12822
    By:
    • Kuo, Chia‐Yu;
    • Tsai, Ming‐Ju;
    • Hung, Jen‐Yu;
    • Lee, Mei‐Hsuan;
    • Wu, Kuan‐Li;
    • Tsai, Yu‐Chen;
    • Chuang, Cheng‐Hao;
    • Huang, Chung‐Wen;
    • Chen, Chin‐Ling;
    • Yang, Chih‐Jen;
    • Chong, Inn‐Wen
    Publication type:
    Article
    34
    35
    36
    37

    Biomarkers of gut barrier dysfunction and risk of hepatocellular carcinoma in the REVEAL‐HBV and REVEAL‐HCV cohort studies.

    Published in:
    International Journal of Cancer, 2023, v. 153, n. 1, p. 44, doi. 10.1002/ijc.34492
    By:
    • Petrick, Jessica L.;
    • Florio, Andrea A.;
    • Zen, Jane;
    • Wang, Yanyu;
    • Gewirtz, Andrew T.;
    • Pfeiffer, Ruth M.;
    • Loftus, Sarah;
    • Inglefield, Jon;
    • Koshiol, Jill;
    • Yang, Baiyu;
    • Yu, Kelly;
    • Hildesheim, Allan;
    • Chen, Chien‐Jen;
    • Yang, Hwai‐I;
    • Lee, Mei‐Hsuan;
    • McGlynn, Katherine A.
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50